Abstract
Non-steroidal anti-inflammatory drugs are frequently used for the treatment of inflammation, pain, and fever. In this study, we found that 2-ethoxybenzamide (ETZ) significantly enhanced melanin synthesis in B16F1 melanoma cells, and also induced melanosome formation. Therefore, we investigated the mechanism by which ETZ up-regulated melanin synthesis. Western blot analysis demonstrated that ETZ increased melanogenic protein levels, except that for TRP-2. Moreover, semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and real-time RT-PCR analyses showed that ETZ enhanced the mRNA levels of melanogenic genes, including microphthalmia-associated transcription factor and melanocortin 1 receptor. We also observed phosphorylation of cAMP response element-binding protein (CREB) following ETZ treatment. However, ETZ did not affect intracellular cAMP levels. ERK was also activated by ETZ treatment, and melanin content was enhanced upon treatment with the specific ERK inhibitor PD98059. Together, our results indicate that ETZ induces melanin synthesis via CREB phosphorylation.
Similar content being viewed by others
References
Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y et al (2000) Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30:73–81
Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B (1998) Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53–64
Rao CV, Redy BS (2004) NSAIDs and chemoprevention. Curr Cancer Drug Targets 4:29–42
Wong BC, Zhu GH, Lam SK (1999) Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 53:315–318
Jana NR (2008) NSAIDs and apoptosis. Cell Mol Life Sci 65:1295–1301
Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL et al (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57:2452–2459
Bhattacharyya S, Ghosh S, Sil PC (2014) Amelioration of aspirin induced oxidative impairment and apoptotic cell death by a novel antioxidant protein molecule isolated from the herb Phyllanthus Niruri. PLoS One 9:e89026
Born G, Patrono C (2006) Antiplatelet drugs. Br J Pharmacol 147(Suppl. 1):S241–S251
Butenas S, Cawthern KM, van’t Veer C, DiLorenzo ME, Lock JB, Mann KG (2001) Antiplatelet agents in tissue factor-induced blood coagulation. Blood 97:2314–2322
Przybyłek M, Ziółkowska D, Mroczynska K, Cysewski P (2016) Propensity of salicylamide and ethenzamide cocrystallization with aromatic carboxylic acid. Eur J Pharm Sci 31:132–140
Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ (2000) Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. J Med Chem 43:2860–2870
Korner A, Pawelek J (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217:1163–1165
Hearing VJ, Tsukamoto K (1991) Enzymatic control of pigmentation in mammals. FASEB J 5:2902–2909
Matoba Y, Kumagai T, Yamamoto A, Yoshitsu H, Sugiyama M (2006) Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis. J Biol Chem 281:981–8990
Decker H, Schweikardt T, Tuczek F (2006) The first crystal structure of tyrosinase: all questions answered? Angew Chem Int Ed 45:4546–4550
Aroca P, Solano F, Salinas C, Garcia-Borron JC, Lozano JA (1992) Regulation of the final phase of mammalian melanogenesis: the role of DOPAchrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur J Biochem 208:155–163
Jackson IJ, Chambers DM, Tsukamoto K, Copeland NG, Gilbert DJ, Jenkins NA, Hearing VJ (1992) A second tyrosinase-related protein, TRP-2, maps to and its mutated at the mouse slaty locus. EMBO J 11:527–535
Kameyama K, Takemura T, Hamada Y, Sakai C, Kondoh S, Nishiyama S, Urabe K, Hearing VJ (1993) Pigment production in murine melanoma cells in regulated by tyrosinase-related protein 1 (TRP-1), DOPAchrome tautomerase (TRP-2), and a melanogenic inhibitor. J Investig Dermatol 100:126–131
Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ (1992) A second tyrosinase-related protein, TRP-2 is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11:519–526
Romeo-Griallet C, Aberdam E, Biagoli N, Massabni W, Ortonne JP, Balloti R (1996) Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 271:28052–28056
Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA (1999) Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 274:16470–16478
Steingrimsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Ann Rev Genet 38:365–411
Bertlotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP et al (1998) Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 142:827–835
Englaro W, Bertolotto C, Busca R, Brunet A, Pages G, Ortonne JP et al (1998) Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem 273:9966–9970
Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET et al (2000) Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 255:135–143
Hemesath TJ, Price ER, Takemoto C, Badalian T, Fisher DE (1998) MAP kinase links the transcription factor microphthalmia to c-kit signaling in melanocyte. Nature 391:298–301
Lee J, Jung E, Park J, Jung K, Park E, Kim J, Hong S, Park J, Park S, Lee S, Park D (2005) Glycyrrhizin induces melanogenesis by elevating a cAMP level in B16 melanoma cells. J Invest Dermatol 124:405–411
Yoon HS, Lee SR, Ko HC, Choi SY, Park JG, Kim JK, Kim SJ (2007) Involvement of extracellular signal-regulated kinase in nobiletin-induced melanogenesis in murine B16/F10 melanoma cells. Biosci Biotechnol Biochem 71:1781–1784
Nishio T, Usami M, Awaji M, Shinohara S, Sato K (2016) Dual effects of acetylsalicylic acid on ERK signaling and Mitf transcription lead to inhibition of melanogenesis. Mol Cell Biochem 412:101–110
Sato K, Takahashi H, Toriyama M (2011) Depigmenting mechanism of NSAIDs on B16F1 melanoma cells. Arch Dermatol Res. 303:171–180
Xia T, Korge P, Weiss JN, Li N, Venkatesen MI, Sioutas C, Nel A (2004) Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ Health Perspect 112:1347–1358
Jin ML, Park SY, Kim YH, Park G, Son HJ, Lee SJ (2012) Suppression of α-MSH and IBMX-induced melanogenesis by cordycepin via inhibition of CREB and MITF, and activation of PI3 K/Akt and ERK-dependent mechanisms. Int J Mol Med 29:119–124
Sato K, Morita M, Ichikawa C, Takahashi H, Toriyama M (2008) Depigmenting mechanisms of all-trans retinoic acid and retinol on B16 melanoma cells. Biosci Biotechnol Biochem 72:2589–2597
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔC(T) method. Methods 25:402–408
Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281:29228–29235
Guthrie HD, Welch GR (2006) Determination of intracellular reactive oxygen species and high mitochondrial membrane potential in Percoll-treated viable boar sperm using fluorescence-activated flow cytometry. J Anim Sci 84:2089–2100
Ashton M, Hanson PJ (2002) Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac. Br J Pharmacol 135:407–416
Busca R, Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60–69
Kumar KJ, Vani MG, Wang SY, Liao JW, Hsu LS, Yang HL et al (2013) In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases. Biofactors 39:259–270
Swope VB, Jameson JA, McFarland KL, Supp DM, Miller WE, McGraw DW et al (2012) Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3. J Invest Dermatol 132:2255–2262
Rouzaud F, Annereau JP, Valencia JC, Costin GE, Hearing VJ (2003) Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FESEB J 17:2154–2156
Garcia-Borron JC, Abdel-Malek Z, Jimenez-Cervantes C (2014) MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation. Pigment Cell Melanoma Res 27:699–720
Su TR, Lin JJ, Tsai CC, Huang TK, Yang ZY, Wu MO et al (2013) Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int J Mol Sci 14:20443–20458
Liang CH, Chou TH, Tseng YP, Ding HY (2012) trans-Caffeic acid stearyl ester from Paeonia suffruticosa inhibits melanin synthesis by cAMP-mediating down-regulation of α-melanocyte-stimulating hormone-stimulated melanogenesis signaling pathway in B16 cells. Biol Pharm Bull 35:21198–22203
Acknowledgments
This work was partially supported by the Japan Society for the Promotion of Science KAKENHI Grant Number 25740018. We are grateful to Hiroaki Nishihira for his technical assistance in this study.
Author contributions
K. S designed the experiments; K. S, R. A, H. K, and T. N performed the experiments; K. S, R. A, and H. K analyzed the data; K. S wrote this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sato, K., Ando, R., Kobayashi, H. et al. 2-Ethoxybenzamide stimulates melanin synthesis in B16F1 melanoma cells via the CREB signaling pathway. Mol Cell Biochem 423, 39–52 (2016). https://doi.org/10.1007/s11010-016-2823-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-016-2823-x